D3

Pressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”

Retrieved on: 
Tuesday, April 2, 2024
Absorption, Açaí palm, Hemp, D3, UST, Business development, CBD, Human, Collection, Marketing, Plant, Commonwealth, Wellness, OTCQB, Animal, Agriculture, Pharmaceutical industry

CANTON, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services for the health & wellness, food & beverage, nutraceutical, cosmeceutical, and other industries, today announced that its wholly-owned Uncle Bud’s Health & Wellness consumer packaged goods subsidiary (“Uncle Bud’s”) has experienced significant sales activity in its revolutionary nanoemulsified CBD product offered in the initial launch of its highly touted “Premium Collection” of UltraShear™ processed nanoemulsion products. Click here for more info on Uncle Bud's Premium Collection.

Key Points: 
  • Click here for more info on Uncle Bud's Premium Collection.
  • The Premium Collection was an immediate success, highlighted by the unprecedented response to its initial product in the Collection - the CBD Body Revive Spray with 1200mg of Nano-CBD.
  • “Uncle Bud’s newly launched Nano-CBD Body Revive Spray, an innovative, all plant-based, organic, highly bioavailable flagship product processed using PBIO’s UltraShear platform, captured an impressive 30% conversion of Uncle Bud’s total CBD Revive Spray product revenue in March alone,” commented John Hollister, PBIO’s Director of Sales and Marketing.
  • This achievement enables PBIO to develop, manufacture, market, and sell UST-processed products into the rapidly expanding CBD marketplace.

Montauk Renewables Announces Full Year 2023 Results

Retrieved on: 
Thursday, March 14, 2024
Kilowatt-hour, Natural gas, Squat toilet, Certificate, D3, Webcast, Sale, Public expenditure, Table, Apex, RIN, Adjustment, GAAP, Security, British thermal unit, Electricity, Primary energy, RNG, Digestion, Bookkeeping

PITTSBURGH, March 14, 2024 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the year ended December 31, 2023.

Key Points: 
  • PITTSBURGH, March 14, 2024 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the year ended December 31, 2023.
  • However, lower prices of both the average realized price of RINs sold and natural gas resulted in lower revenues in 2023.
  • These 2023 price driven reductions to revenues of approximately $30.7 million were offset through our tiered royalty structure reducing royalty expense in 2023 by approximately $9.3 million, which led to our $20.9 million reduction in 2023 operating income.
  • Our average pricing realized on RIN sales during 2023 of $2.71 exceeded the average D3 RIN index price of $2.63 during 2023.

Nutrex-Hawaii Introduces Its #1 Selling BioAstin® Hawaiian Astaxanthin® in a Retail-Ready, Sugar-Free, Vegan Gummy Format

Retrieved on: 
Thursday, March 28, 2024
Men, Retail, Health, Consumer, Convenience Store, Lifestyle, General Health, Supermarket, Specialty, Fitness & Nutrition, Women, Seniors, Food, Beverage, Organic Food, D3, Beauty, Eye, UV, Vitamin C, Stevia, Skin, Dietary supplement

Nutrex-Hawaii, Inc., a wholly owned subsidiary of Cyanotech Corporation, unveils its #1 selling BioAstin® Hawaiian Astaxanthin® dietary supplement in a groundbreaking sugar free gummy format, enriched with an industry-leading 12mg of natural Hawaiian Astaxanthin per daily serving.

Key Points: 
  • Nutrex-Hawaii, Inc., a wholly owned subsidiary of Cyanotech Corporation, unveils its #1 selling BioAstin® Hawaiian Astaxanthin® dietary supplement in a groundbreaking sugar free gummy format, enriched with an industry-leading 12mg of natural Hawaiian Astaxanthin per daily serving.
  • "Today's consumers seek brands that align with their values of efficacy, transparency, and sustainability.
  • "With antioxidant potency 6000 times greater than Vitamin C, our BioAstin® Hawaiian Astaxanthin® gummies provide consumers with powerful benefits for full body wellness.
  • For more information about Nutrex-Hawaii and BioAstin® Hawaiian Astaxanthin® gummies, please visit https://www.nutrex-hawaii.com .

Verde Clean Fuels, Inc. Reports 2023 Results

Retrieved on: 
Thursday, March 28, 2024
Alternative Energy, Energy, Oil, Gas, Permian, STG, Natural gas, Joint, Diamondback Energy, Gasoline, D3, FID, Research, Carbon, Fuel pump, JDA, GAAP, LCFS, Engineering, FANG

Verde Clean Fuels, Inc. (“Verde” or the “Company”) (Nasdaq: VGAS), a renewable energy company focused on the development of commercial production plants to convert syngas derived from diverse feedstocks into gasoline, today reported full year 2023 GAAP diluted net loss per share of $(0.45).

Key Points: 
  • Verde Clean Fuels, Inc. (“Verde” or the “Company”) (Nasdaq: VGAS), a renewable energy company focused on the development of commercial production plants to convert syngas derived from diverse feedstocks into gasoline, today reported full year 2023 GAAP diluted net loss per share of $(0.45).
  • Verde is continuing the selection process for FEED/EPC services for the Cottonmouth Ventures Permian Basin project.
  • Verde is proceeding with selection of a front end engineering and design (“FEED”) partner and an engineering, procurement, and construction (“EPC”) partner.
  • With the execution of the Cottonmouth Ventures JDA, Verde expects to finalize its partner selections soon.

PopCorners® and Actor Don Cheadle Get Caught with Something Good™ in Speakeasy-Themed Commercial

Retrieved on: 
Wednesday, March 20, 2024
NBCU, D3, Kettle corn, Pajamas, Life, Philadelphia Cream Cheese, AMC, Warner Bros. Discovery, Marketing

PLANO, Texas, March 20, 2024 /PRNewswire/ -- Known for delivering a delicious, crunchy popped-corn snack that fans desire, PopCorners® continues to break convention and unlock snacking possibilities by delivering a great tasting product that is never fried. Today, the brand launches a campaign that adds a twist to an often-clandestine setting.

Key Points: 
  • The new commercial, called "Get Caught with Something Good™", stars award-winning actor Don Cheadle as a mysterious speakeasy host, secretly serving his favorite PopCorners to guests who arrive expecting to enjoy something bad but get caught with something good.
  • "I was excited to work with PopCorners on this commercial and promote a product I love — particularly the White Cheddar flavor," says Cheadle.
  • The commercial was directed by Noam Murro who collaborated with Cheadle on the creative direction.
  • "This year, 'Get Caught with Something Good' continues to insert PopCorners into unconventional situations with a Prohibition-era hidden speakeasy."

Aemetis Reports 2023 Fourth Quarter and Year-End Results

Retrieved on: 
Thursday, March 7, 2024
Engineering, Collection, Operating cost, The Twelve Months, Ethanol, Aviation, Renewable natural gas, Natural gas, Growth, Sale, CEQA, Authority, Adjustment, Carbon, D3, Construct, CO2, Public expenditure, Acceleration, IRA, Three Months, Investment, USDA, Video game

CUPERTINO, CA, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity products, today announced its financial results for the fourth quarter and twelve months ended December 31, 2023.

Key Points: 
  • “Revenues were $70.8 million for the fourth quarter of 2023, an increase from $66.7 million for the fourth quarter of 2022.
  • Financial Results for the Three Months Ended December 31, 2023
    Revenues were $70.8 million for the fourth quarter of 2023, an increase from $66.7 million for the fourth quarter of 2022.
  • The ethanol gallons sold increased from 13.4 million gallons during the fourth quarter of 2022 to 15 million gallons during the fourth quarter of 2023.
  • Selling, general and administrative expenses rose from $7.5 million during the fourth quarter of 2022 to $9.8 million during the fourth quarter of 2023.

Meeker Aviation Receives EASA Certification for EC-145 C2/D2 & D3 Step Mount

Retrieved on: 
Monday, February 26, 2024
Airbus, H145, EASA, Transport Canada, Aviation, D3, Aircraft, ENG, FLIR

OCEANSIDE, Calif., Feb. 26, 2024 /PRNewswire/ -- Meeker Aviation, a leading provider of aircraft payload mounts, today announced that it has received EASA approval for its Utility Step Mount for all models of the Airbus H145 aircraft, including the newest D3 variant.

Key Points: 
  • OCEANSIDE, Calif., Feb. 26, 2024 /PRNewswire/ -- Meeker Aviation, a leading provider of aircraft payload mounts, today announced that it has received EASA approval for its Utility Step Mount for all models of the Airbus H145 aircraft, including the newest D3 variant.
  • This Utility Step Mount has already received FAA and Transport Canada certification.
  • "Our very popular H145/BK117 Utility Step Mount provides operators with a robust design, dual payload capability, and exceptional camera stability," said Cal Meeker, President of Meeker Aviation.
  • "We are pleased to now be able to offer this product to our customers worldwide so that they can take advantage of the many benefits our side step mount provides."

Nordic Naturals Issues Voluntary Recall of Baby's Vitamin D3 Liquid Due to Elevated Levels of Vitamin D3

Retrieved on: 
Saturday, February 17, 2024
FDA, Urination, Natural, Health, D3, SKU, Vitamin D, Somatic symptom disorder, Thirst, Vomiting, Cholecalciferol, PST, Dietary supplement

WATSONVILLE, Calif., Feb. 17, 2024 (GLOBE NEWSWIRE) -- Nordic Naturals is voluntarily recalling one lot of Nordic Naturals Baby’s Vitamin D3 Liquid, 0.76 fl.

Key Points: 
  • WATSONVILLE, Calif., Feb. 17, 2024 (GLOBE NEWSWIRE) -- Nordic Naturals is voluntarily recalling one lot of Nordic Naturals Baby’s Vitamin D3 Liquid, 0.76 fl.
  • This recall is being conducted due to a manufacturing error that resulted in an elevated level of Vitamin D3 dosage or super potent dose.
  • Prolonged use of the recalled Baby’s Vitamin D3 Liquid could potentially lead to elevated vitamin D levels, resulting in vomiting, loss of appetite, increased thirst, frequent urination, and inability to thrive in infants.
  • Nordic Naturals can also be contacted directly at [email protected] or 888-294-7440, Monday – Friday, 8:00 a.m. - 5:00 p.m. PST.

PathogenDx Launches Novel D3 Array Multiplexed Molecular Diagnostics Technology for Urinary Tract Infection (UTI) Pathogen Detection and Antibiotic Resistance

Retrieved on: 
Wednesday, February 7, 2024
Workflow, Patient, Safety, Pain, Running, Diagnosis, Urinary tract infection, Temperature, Sepsis, Laboratory, Data analysis, Real-time, Physician, Pyelonephritis, D3, Health, UTI, PCR

Powered by the Company's novel multiplexed molecular diagnostics technology, D3 Array™-UTI features testing in triplicate for quality assurance, with qualitative and quantitative results in the same reaction, as well as automated, cloud-based data analysis, reporting and management.

Key Points: 
  • Powered by the Company's novel multiplexed molecular diagnostics technology, D3 Array™-UTI features testing in triplicate for quality assurance, with qualitative and quantitative results in the same reaction, as well as automated, cloud-based data analysis, reporting and management.
  • "Providing a proper UTI diagnosis is a race against the clock," said PathogenDx Co-founder and CEO, Milan Patel .
  • "An individual is risking continued pain and discomfort, chronic infections, kidney infection, and in severe cases, sepsis.
  • The array is equipment agnostic, making it compatible with routine molecular instrumentation and existing workflow.

Gate.io and D3 Partner to Apply for and Obtain '.Gate' Top-Level Domain

Retrieved on: 
Friday, February 2, 2024
Partnership, DNS, Internet, ICANN, TLD, D3, Ecosystem

This move makes Gate.io the first cryptocurrency exchange to express interest in pursuing its own dedicated TLD.

Key Points: 
  • This move makes Gate.io the first cryptocurrency exchange to express interest in pursuing its own dedicated TLD.
  • TLDs are the last part of website addresses, maintained in the Internet's Domain Name System (DNS).
  • Similar decentralized blockchain-based systems, utilizing extensions such as ".eth" and ".crypto," are incompatible with the conventional web's DNS.
  • By partnering with D3, Gate.io continues to showcase its position as an innovator in the market.